bioRxivCancer Biology
In vivo targeted and deterministic single cell malignant transformation
P. Scerbo, B. Tisserand, M. Delagrange, H. Debare, D. Bensimon, B. Ducos
Abstract
Why does a normal cell possibly harboring genetic mutations in oncogene or tumor suppressor genes becomes malignant and develops a tumor is a subject of intense debate. Various theories have been proposed but their experimental test has been hampered by the unpredictable and improbable malignant transformation of single cells. Here using an optogenetic approach we permanently turn on an oncogene (KRASG12V) in a single cell of a zebrafish brain that, only in synergy with the transient co-activation of a reprogramming factor (VENTX/NANOG/OCT4), undergoes a deterministic malignant transition and robustly and reproducibly develops within 6 days into a full-blown tumor. The controlled way in which a single cell can thus be manipulated to give rise to cancer lends support to the "ground state theory of cancer initiation" through "short-range dispersal" of the first malignant cells preceding tumor growth.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cancer cell exosomes can initiate malignant cell transformation
Karoliina Stefanius, Kelly A. Servage, … Kim Orth·bioRxiv·Jul 3, 2018
- Generation Of A Double Binary Transgenic Zebrafish Model To Study Myeloid Gene Regulation In Response To Melanocyte Transformation
Amy Kenyon, Daria Gavriouchkina, … Tatjana Sauka‐Spengler·Disease Models & MechanismsPeer-reviewed·Jan 1, 2018
- Oncogenic Ras activation in permissive somatic cells triggers rapid onset phenotypic plasticity and elicits a tumour-promoting neutrophil response
A. M. Elliot, I. Ribeiro Bravo, … Y. Feng·bioRxiv·Nov 10, 2023
- Tracking the cells of tumor origin in breast organoids by light sheet microscopy
A. Alladin, L. Chaible, … M. Jechlinger·bioRxiv·Apr 24, 2019
- Origin of Ewing sarcoma by embryonic reprogramming of neural crest to mesoderm
Elena Vasileva, Claire Arata, … James F. Amatruda·Cell ReportsPeer-reviewed·Oct 1, 2025
- Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.
R. E. Ito, C. Oneyama, K. Aoki·bioRxiv·May 26, 2020